Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Modeling HIV infection, treatment, rebound, and intervention in human immune organoids.

bioRxiv : the preprint server for biology·2026

Same author

Leveraging HIV-Specific CAR T Cells and Rapamycin Treatment in "Kick-and-Kill" HIV Cure Approaches.

bioRxiv : the preprint server for biology·2026

Same author

NK Cells Engineered with a Chimeric Antigen Receptor Delay HIV Rebound and Reshape HIV Reservoir Composition.

bioRxiv : the preprint server for biology·2026

Same author

Author Correction: Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns.

Nature communications·2025

Same author

Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns.

Nature communications·2025

Same author

Rapamycin enhances CAR-T control of HIV replication and reservoir elimination in vivo.

The Journal of clinical investigation·2025

Search research articles

相关实验视频

Updated: Apr 25, 2026

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

中和艾滋病毒储存库.

Matthew D Marsden¹, Jerome A Zack²

¹Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA 90095, USA; UCLA AIDS Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA.

|August 30, 2014

概括

广泛中和抗体与艾滋病毒潜伏激活剂相结合,在人性化的小鼠模型中减少了持续的艾滋病毒储存库. 这种方法对清除潜伏的艾滋病毒有希望,这是朝着治愈艾滋病毒迈出的关键一步.

更多相关视频

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

相关实验视频

Last Updated: Apr 25, 2026

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

科学领域:

免疫学免疫学免疫学
病毒学病毒学
传染性疾病传染性疾病

背景情况:

持久的艾滋病毒储存库是治愈艾滋病毒感染的主要障碍.
目前的抗逆转录病毒疗法可以控制病毒复制,但不能消除潜伏的HIV.
需要新的战略来准和清除这些潜伏的水库.

研究的目的:

研究广泛中和抗体 (bNAbs) 与艾滋病毒潜伏激活剂结合的疗效.
为了确定这种组合疗法是否可以在体内减少持久的HIV储存.
评估治疗停止后对病毒反弹的影响.

主要方法:

利用人类免疫细胞植入并感染艾滋病毒的人性化小鼠模型.
使用了bNAbs和延迟激活化合物的组合.
在治疗后监测血HIVRNA水平和测量储大小.

主要成果:

组合疗法显著减少了持久性艾滋病毒储存量.
观察到病毒载荷减少,这表明血病毒反弹延迟或不存在.
这表明了艾滋病毒储清除的潜在策略.

结论:

广泛中和抗体与潜伏激活剂相结合,可以有效地减少潜伏的HIV储存库.
这种治疗方法为艾滋病毒治愈研究提供了一个有希望的策略.
需要在临床环境中进行进一步的研究来转化这些发现.